Chengdu Bright Eye Hospital Co Ltd
SZSE:301239
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
28.83
86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Chengdu Bright Eye Hospital Co Ltd
Total Equity
Chengdu Bright Eye Hospital Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Chengdu Bright Eye Hospital Co Ltd
SZSE:301239
|
Total Equity
¥2.3B
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Total Equity
¥19.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
25%
|
CAGR 10-Years
26%
|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Total Equity
¥2.3B
|
CAGR 3-Years
214%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
9%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Total Equity
¥3.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
10%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Total Equity
¥5.7B
|
CAGR 3-Years
59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Total Equity
¥2.3B
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chengdu Bright Eye Hospital Co Ltd
Glance View
Chengdu Bright Eye Hospital Co Ltd. emerged as a beacon in the healthcare sector, nestled in the bustling city of Chengdu, China. The company carved its niche by focusing on a clear vision—literally and figuratively—through specializing in ophthalmic services. This focus on eye health is not only crucial in a densely populated region but also timely, as urban lifestyles contribute to rising eye health issues. With a commitment to offering comprehensive eye care, the hospital provides a range of services from basic eye examinations and common procedures like cataract surgeries, to advanced treatments involving laser technologies. This broad spectrum of services addresses the varied needs of patients, ensuring a continuous flow of clients from consultations to complex surgical interventions. The hospital operates in a competitive market but distinguishes itself by leveraging modern technology and an emphasis on patient-centric care. Its financial model is built around both volume and specialization, attracting patients through quality and trust. Revenue flows from direct payments for services rendered and strategic alliances with insurance companies that subsidize eye care treatments. Additionally, the hospital invests in community outreach and education, raising awareness about eye health and driving traffic to its facilities. Through a combination of strategic location, a diversified service portfolio, and a reputation for medical excellence, Chengdu Bright Eye Hospital not only captures a significant share of the regional eye care market but also sets a precedent for service-driven profitability in the healthcare sector.
See Also
What is Chengdu Bright Eye Hospital Co Ltd's Total Equity?
Total Equity
2.3B
CNY
Based on the financial report for Dec 31, 2023, Chengdu Bright Eye Hospital Co Ltd's Total Equity amounts to 2.3B CNY.
What is Chengdu Bright Eye Hospital Co Ltd's Total Equity growth rate?
Total Equity CAGR 3Y
39%
Over the last year, the Total Equity growth was 11%. The average annual Total Equity growth rates for Chengdu Bright Eye Hospital Co Ltd have been 39% over the past three years .
You don't have any saved screeners yet
